A novel dual-function SERS-based identification strategy for preliminary screening and accurate diagnosis of circulating tumor cells

Author:

Zhang Dinghu123,Lin Jie23,Xu Yanping123,Wu Xiaoxia123,Xu Xiawei23,Xie Yujiao23,Pan Ting1,He Yiwei1,Luo Jun1,Zhang Zhewei1,Fan LinYin1,Li Shunxiang23,Chen Tianxiang23,Wu Aiguo23ORCID,Shao Guoliang1

Affiliation:

1. Department of Interventional Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China

2. Ningbo Cixi Institute of Biomedical Engineering, International Cooperation Base of Biomedical Materials Technology and Application, Chinese Academy of Science (CAS) Key Laboratory of Magnetic Materials and Devices and Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering, CAS, Ningbo 315201, P. R. China

3. Advanced Energy Science and Technology Guangdong Laboratory, Huizhou 516000, P. R. China

Abstract

Fe3O4–Au complex SERS bioprobe could effectively capture the TNBC and endow the tumor cells with remarkable SERS signals. Detection sensitivity and specificity of CTCs could be intelligently switched according to identification purposes.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Recent advances in plasmonics for liquid biopsy: A short review;Materials Today Communications;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3